Firstly, we acknowledge that Genpact has a significantly high ROE. Additionally, the company's ROE is higher compared to the industry average of 16% which is quite remarkable. This likely paved the ...

Genpact (NYSE:G – Free Report) had its price objective boosted by Robert W. Baird from $38.00 to $44.00 in a research note ...

Investors need to pay close attention to Genpact (G) stock based on the movements in the options market lately.

Genpact offices at 6737 Southpoint Drive S. in South Jacksonville. Genpact Ltd. said in a Sept. 26 notice under the Worker ...

Genpact's new 3+1 Execution Framework and external tailwinds are driving improved performance and competitive advantages. Its Q2-2024 results exceeded revenue and EPS estimates, showcasing strong ...

FinTech LIVE 2024 is just a week away! Explore the full speaker lineup and get ready to connect with top fintech leaders. Don ...

GenAI is undoubtedly changing how data scientists and analysts work, including tools, processes, and deliverables. Here’s ...

Partners and clients across industries gather at exclusive eventNEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G ), a ...

Genpact (G) is a stock many investors are watching right now. G is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 11.73 right now.

NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, hosted its AI Day today, bringing together ...